⌘K

Home/Insiders/Kollins John A

KJ

SEC Insider//CIK 0001391070

Kollins John A

CIK 00013910701 companySOUTH SAN FRANCISCO, CA

Transactions

11

Companies

1

Filings

4

CIK

0001391070

Recent Transactions

11 trades

Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−505,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−175,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−276,595→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−240,000→ 0 total
Disposition to Issuer
Satsuma Pharmaceuticals, Inc.
Stock Option (right to buy)
2023-06-08−127,659→ 0 total
Disposition from Tender
Satsuma Pharmaceuticals, Inc.
Common Stock, $0.0001 par value
2023-06-06$0.91/sh−305,911→ 0 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2022-06-03+505,000→ 505,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-12-03+240,000→ 240,000 total
Award
Satsuma Pharmaceuticals, Inc.
Stock Option (Right to Buy)
2020-03-04+175,000→ 175,000 total

Companies

1

Satsuma Pharmaceuticals, Inc.
Director, President and CEO

Recent Filings

4

Address

SATSUMA PHARMACEUTICALS, INC. 400 OYSTER POINT BOULEVARD, SUITE 221

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov